This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Urologix Announces Election Of Christopher R. Barys As Director

MINNEAPOLIS, Aug. 10, 2010 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), announced Christopher R. Barys has joined the Board of Directors effective August 6, 2010.

"We are pleased and excited to welcome Chris Barys to the Urologix Board," stated Mr. Warren. "In addition to his senior leadership and operating experience in medical technology companies, Chris complements existing Urologix Board expertise with his strong background in Sales and Marketing - a key element to the Company's continued effort to firmly establish Cooled ThermoTherapy™ as a first-line, definitive therapeutic alternative to BPH medications." 

Mr. Barys has spent 20 years in the medical field and was most recently Chief Operating Officer at FlowCardia - a company providing endovascular tools for crossing chronic total occlusions (CTOs) in the leg and coronary arteries. Chris has spent over 15 years in the interventional space including senior positions at Edwards LifeSciences as Vice President of Leadership Development and as Vice President of Sales and Marketing for the Peripheral Vascular Systems business for Edwards where he had broad responsibility for the fastest growing franchise within the company. Previously, Chris held senior Sales and Marketing positions at Johnson & Johnson's Cordis Cardiology division, Boston Scientific's Vascular Division and U.S. Surgical. Chris received his BS degree in Marketing from Northern Illinois University.

Mr. Barys stated, "I am pleased to be joining such an experienced board and look forward to providing leadership support. There are so many different treatment options offered for BPH that the average patient becomes very confused about what might be the most efficacious treatment. Cooled ThermoTherapy™ has established itself as one of the most successful and efficacious treatment options for patients."

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,424.85 +162.29 1.00%
S&P 500 1,862.31 +19.33 1.05%
NASDAQ 4,086.2250 +52.0640 1.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs